跳至主要内容
临床试验/IRCT201307205280N14
IRCT201307205280N14已完成未知

The effect of adding topiramate (compared to placebo) in reducing withdrawal symptoms in opium-like substances in the substance-dependent patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 years 至 59 years(—)
性别
Male

入选标准

  • Individuals are included if they fulfil DSM-IV-TR criteria for opioid- like substance dependency. However, Patients are not included if they have opioid- like withdrawal syndrome during the recruitment period.
  • Exclusion criteria: concomitant use of alcohol, stimulants as well as benzodiazepines; having severe medical comorbidities; patients who start to take any psychiatric medication or any significant change in dose of medication during the study and follow-up period.

排除标准

  • 未提供

研究者

相似试验